TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

Consultant Connect & NHS South Yorkshire Integrated Care Board (SYICB) Tele-dermatology USC Emergency Provision 2024/25 (Ref: CC&SYICBTDUSCEP2024-25)

Dermatology services
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS South Yorkshire Integrated Care Board: "Consultant Connect & NHS South Yorkshire Integrated Care Board (SYICB) Tele-dermatology USC Emergency Provision 2024/25 (Ref: CC&SYICBTDUSCEP2024-25)". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityNHS South Yorkshire Integrated Care BoardScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: NHS South Yorkshire Integrated Care Board
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for NHS South Yorkshire Integrated Care Board. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
1Bids / Report
99.5% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 651 active published awards; 645 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSNot published
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published3 Jan 2025, 15:29 GMT
Last source update3 Jan 2025, 15:29 GMT
Recurring procurementNot published
ClassificationDermatology services
OCIDocds-h6vhtk-04cd65
What is being bought
Tele-dermatology for Sheffield: A consultant triage provision for urgent suspected skin cancer referrals from primary care. The triage will result in; referral being sent to the secondary care urgent suspected cancer (USC) pathway, or, the referral being sent to the routine secondary care dermatology pathway, or, the referral being sent back to primary care with advice and guidance.
What changed
From the official release history
  1. Status changed to complete
    3 Jan 2025, 15:29 GMT
  2. Official notice release published
    3 Jan 2025, 15:29 GMT
  3. Buyer information updated
    3 Jan 2025, 15:29 GMT
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    cancelled
    Published valueNot published
    The following has been prepared in accordance with regulation 14 of The Health Care Services (Provider Selection Regime) Regulations 2023 (PSR).<br/><br/>The reasons why regulation 14 applied:<br/><br/>Regulation 14(2)(a): The authority considers that the award must be made urgently<br/>STH have recently been under increasing national scrutiny as the worst performer in the country for the Faster Diagnosis Standard in skin cancer which is being correlated with them being the only provider without a comprehensive tele dermatology service. Tier 1 conversations have requested urgent action to recover this position. <br/><br/>Some short term waiting list initiatives have been implemented to improve the position but this remains fragile due to ongoing capacity constraints and there still being insufficient capacity to match demand. There is well-recognised seasonal variation with skin cancer referrals leading to increased referrals over summer when the service is often most stretched for capacity. There are also concerns regarding waiting times for non-skin cancer conditions which have a serious quality of life implication. Awarding the teledermatology contract will allow consultant led triage of the urgent suspected cancers ensuring that the referrals into STHFT are limited to those definitely requiring secondary care input and releasing capacity to manage the whole PTL. <br/><br/>Regulation 14(2)(b): The reason for the urgency was not foreseeable by and not attributable to the relevant authority<br/>Less than 6 months ago STH were performing above the FDS target for skin and whilst performance declined during the winter it was not expected that this would drop as significantly below target as it did and continuing on a downward trajectory. A local incentivisation scheme was implemented to ensure dermatology image capture in primary care but this has not yielded the productivity gains that have been demonstrated by utilisation of a tele-dermatology provider.<br/>The reason for the poor performance is not attributable to SYICB but a result of combined demand and capacity pressures at STH. <br/><br/>Regulation 14(2)(c): Delaying the award of the contract to satisfy the requirements of the other relevant PSR regulations would likely pose a risk to patient or public safety<br/>There is an immediate risk to patient safety due to delays in cancer diagnosis. The FDS is described by NHS England as being essential to ensure patients who are diagnosed with cancer can begin their treatment as soon as possible, and put those who are not diagnosed with cancer at ease sooner (see https://www.england.nhs.uk/cancer/faster-diagnosis/). The aim of this emergency tele-dermatology provision is to reduce the number of referrals on the USC skin pathway at STH (slowing demand) by ensuring only those genuine USCs are referred on the USC pathway and start their treatment as soon as possible.<br/><br/>The lifetime value of the contract is not known however the amounts payable to the provider under the contract are:<br/>£3,600 one off set-up fee<br/>£42.50 per referral received by the Provider; it is anticipated that there are 405 Sheffield urgent suspected skin cancer referrals per month. <br/><br/>The dates between which the contract provides for services to be provided<br/>6 months from 5th December 2024 with an option to extend on a rolling monthly basis for an additional 6 months (total contract term maximum of 12 months).<br/>Rolling extension will be used where:<br/>a) provision identifies a reduction in demand on the USC skin pathway in Sheffield; <br/>b) this reduction in demand is contributing to the skin Faster Diagnosis Standard (FDS) recovery at Sheffield Teaching Hospitals NHS Foundation Trust (STH); and<br/>c) if a provision is deemed as required in Sheffield post the initial 6 months, to allow time for any procurement and mobilisation to take place.<br/><br/>A full procurement is likely to take in excess of 6 months and SYICB believe that urgent provision is needed at pace to sustain the recovery of the FDS.<br/><br/>SYICB already commissions Consultant Connect (awarded under the Public Contracts Regulations 2015) for GPs to upload any dermatoscopic images and normal camera images for review (triage / diagnosis). Using Consultant Connect means that GPs are asked to use software for the emergency; provision that they are already familiar with meaning no additional information technology requirements are needed to mobilise an emergency provision at pace. In addition, Consultant Connect will not require any additional equipment to be made available to primary care to support an ‘emergency’ provision and can use the existing cameras and dermatoscopes. <br/><br/>The timescales required to undertake a competitive procurement and then mobilise a new provider (in excess of 6 months) means that there would be a delay in recovering the cancer FDS position, which would pose a risk to patient safety through delayed diagnosis and treatment to cancer, as earlier described. If a decision is made that tele-dermatology is needed in Sheffield by SYICB post this the emergency provision the appropriate alternative process under the Provider Selection Regime will be applied.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    3 Jan 2025, 15:29 GMT
  2. Award active
    Not published · Not published
  3. Contract active
    Signed 5 Dec 2024, 00:00 GMT · £1
Commercial outcome and competition
Awards
Consultant Connect
Not published · Not published · active
Contracts
Contract
£1 · signed 5 Dec 2024, 00:00 GMT · active
Bid statistics
bids: 1 (lot 1)
Buyer and organisations in this procedure

NHS South Yorkshire Integrated Care Board

Contracting authority GB-FTS-113634
View buyer profile
  • NHS South Yorkshire Integrated Care Board
    buyer

    197 Eyre Street, Sheffield, UKE32, S1 3FG
  • Consultant Connect
    supplier

    Oxford, UKE3, OX1 1DE
  • Independent Choice and Procurement Panel.
    reviewBody

    Wellington House, London, SE1 8UG
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published
Planning and rationale
Planning budgetNot published
No-engagement rationaleNot published
Procedure rationale8. The reasons why regulation 14 applied:<br/><br/>Regulation 14(2)(a): The authority considers that the award must be made urgently<br/>STH have recently been under increasing national scrutiny as the worst performer in the country for the Faster Diagnosis Standard in skin cancer which is being correlated with them being the only provider without a comprehensive tele dermatology service. Tier 1 conversations have requested urgent action to recover this position. <br/><br/>Some short term waiting list initiatives have been implemented to improve the position but this remains fragile due to ongoing capacity constraints and there still being insufficient capacity to match demand. There is well-recognised seasonal variation with skin cancer referrals leading to increased referrals over summer when the service is often most stretched for capacity. There are also concerns regarding waiting times for non-skin cancer conditions which have a serious quality of life implication. Awarding the teledermatology contract will allow consultant led triage of the urgent suspected cancers ensuring that the referrals into STHFT are limited to those definitely requiring secondary care input and releasing capacity to manage the whole PTL. <br/><br/>Regulation 14(2)(b): The reason for the urgency was not foreseeable by and not attributable to the relevant authority<br/>Less than 6 months ago STH were performing above the FDS target for skin and whilst performance declined during the winter it was not expected that this would drop as significantly below target as it did and continuing on a downward trajectory. A local incentivisation scheme was implemented to ensure dermatology image capture in primary care but this has not yielded the productivity gains that have been demonstrated by utilisation of a tele-dermatology provider.<br/>The reason for the poor performance is not attributable to SYICB but a result of combined demand and capacity pressures at STH. <br/><br/>Regulation 14(2)(c): Delaying the award of the contract to satisfy the requirements of the other relevant PSR regulations would likely pose a risk to patient or public safety<br/>There is an immediate risk to patient safety due to delays in cancer diagnosis. The FDS is described by NHS England as being essential to ensure patients who are diagnosed with cancer can begin their treatment as soon as possible, and put those who are not diagnosed with cancer at ease sooner (see https://www.england.nhs.uk/cancer/faster-diagnosis/). The aim of this emergency tele-dermatology provision is to reduce the number of referrals on the USC skin pathway at STH (slowing demand) by ensuring only those genuine USCs are referred on the USC pathway and start their treatment as soon as possible.